Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Monogatari, Jan-Mar (3Q) Ordinary Profit Decreases by 7%
3097 The Monogatari Corporation 【J-GAAP】
Earnings ReportThe Monogatari Corporation <3097> [TSE Prime] announced its financial results after the market closed on May 9th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending June 2025 (July 2024 to March 2025) was 6.82 billion yen, a 2.3% decrease compared to the same period last year. The progress rate toward the full-year plan of 9.53 billion yen was 71.6%, also falling below the five-year average of 93.4%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the April to June period (4Q) is expected to expand 70.1% from the same period last year, reaching 2.71 billion yen.
In the most recent three-month period, from January to March (3Q), the consolidated ordinary profit decreased to 2.55 billion yen, a 6.6% decrease compared to the same period last year. The operating profit margin worsened from 9.3% in the same period last year to 8.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Mar, 2022 | 68,355 | 5,631 | 5,575 | 3,531 | 97.2 | 77.7 | May 10, 2023 | J-GAAP |
Jul - Mar, 2023 | 80,588 | 6,874 | 6,988 | 4,166 | 116.9 | 81.4 | May 10, 2024 | J-GAAP |
Jul - Mar, 2024 | 92,579 | 6,939 | 6,827 | 4,590 | 122.4 | 71.6 | May 9, 2025 | J-GAAP |
YoY | +14.9% | +0.9% | -2.3% | +10.2% | +4.8% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 55,151 | 3,955 | 4,326 | 3,180 | 89.2 | 17 | Aug 9, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 61,629 | 5,247 | 5,264 | 3,559 | 92.4 | 18 | Feb 10, 2025 | J-GAAP |
YoY | +11.7% | +32.7% | +21.7% | +11.9% | +3.6% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jun, 2023 | 92,274 | 7,202 | 7,179 | 4,693 | 129.5 | 26.67 | Aug 10, 2023 | J-GAAP |
Jun, 2024 | 107,156 | 8,165 | 8,582 | 5,639 | 158.2 | 32 | Aug 9, 2024 | J-GAAP |
Jun, 2025 Guidance | 121,534 | 9,580 | 9,538 | 6,323 | 164.2 | 36 | Aug 9, 2024 | J-GAAP |
YoY | +13.4% | +17.3% | +11.1% | +12.1% | +3.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 28,583 | 2,664 | 2,732 | 1,707 | 47.9 | 9.3 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 26,568 | 1,291 | 1,594 | 1,473 | 41.3 | 4.9 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 29,752 | 2,363 | 2,236 | 1,314 | 36.6 | 7.9 | Nov 8, 2024 | J-GAAP |
Oct - Dec, 2024 | 30,153 | 1,970 | 2,038 | 1,450 | 39.2 | 6.5 | Feb 10, 2025 | J-GAAP |
Jan - Mar, 2025 | 32,674 | 2,606 | 2,553 | 1,826 | 48.7 | 8.0 | May 9, 2025 | J-GAAP |
YoY | +14.3% | -2.2% | -6.6% | +7.0% | +1.7% |
Related Articles
BrightPath Biotherapeutics, Continue Net Income Turns to Loss
Sansha Electric Manufacturing, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 2% Increase in Ordinary Profit for The Current Fiscal Year
JANOME, 6% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 15 yen
COLOWIDE, 70% Increase in Net Income for The Current Fiscal Year
RENAISSANCE INC, 14% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen
KATITAS, 13% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 14 yen
Japan Hospice, Jan-Mar (1Q) Ordinary Profit Decreases by 59%
CORONA, 18% Decrease in Ordinary Profit for The Current Fiscal Year
OKAMURA, 11% Increase in Ordinary Profit, Update Record High for Seventh Consecutive Term, Increased Previous Year's Dividend by 4 yen, This Fiscal Year to Increase Dividend by 10 yen
TOWA, 4% Increase in Ordinary Profit for The Current Fiscal Year